R

RD Fund

3 employees

Retinal Degeneration Fund makes mission-related investments in therapeutic companies with projects nearing clinical testing.

Investor insights

Sectors invested in

Biotechnology5
Health Care4
Therapeutics4
Life Science3
Pharmaceutical1
Genetics1
Biopharma1
Cell therapy1
Gene therapy1
Genetic disease1
Genome engineering1
Inherited disease1
Cell engineering1

Funding rounds participated in

$66M sweet spot round size

Most of their 8 investments are in rounds between $19M and $77M

Investor type

Corporate Venture Capital

Basic info

Industry

research services

Sectors

Financial Services
Therapeutics
Business Development

Date founded

2018

Investments made

P

Perceive Biotherapeutics, Inc. raised $78M on January 5, 2023

Investors: Catalio Capital Management, Braidwell and RD Fund

S

SparingVision raised $75M on September 14, 2022

Investors: UPMC Enterprises, Ysios Capital, JEITO and RD Fund

N

NACUITY PHARMACEUTICALS, INC. raised $17M on June 15, 2022

Investors: Maxim Group and RD Fund

S

SalioGen Therapeutics raised $115M on January 5, 2022

Investors: GordonMD Global Investments LP, T. Rowe Price, EPIQ, D1 Capital Partners L.P. and RD Fund

U

Undisclosed raised $19M on September 22, 2021

Investors: Bios Partners and RD Fund

V

Vedere Bio II raised $77M on May 18, 2021

Investors: Octagon Capital Advisors, Samsara BioCapital, Casdin Capital, LLC, Atlas Venture and RD Fund

A

Atsena Therapeutics raised $55M on December 16, 2020

Investors: Abingworth, Sofinnova Ventures, Russia technology fund, Lightstone Ventures, Osage University Partners (OUP) and RD Fund

U

Undisclosed raised $57M on November 9, 2020

Investors: Novo Holdings, venBio Partners, Pontifax Venture Capital, Canaan and RD Fund

FAQ